南财智讯8月12日电，亿胜生物科技（01061.HK）公告，截至2026年6月30日止六个月，公司实现收益784694000港元，折合7.85亿港元；上年同期为876535000港元，同比下降10.48%。可报告分部溢利为190762000港元，折合1.91亿港元；上年同期为242068000港元。本公司拥有人应占每股盈利为19.53港仙，上年同期为28.82港仙。（文章来源：南方财经网）
Source Link南财智讯8月12日电，亿胜生物科技（01061.HK）公告，截至2026年6月30日止六个月，公司实现收益784694000港元，折合7.85亿港元；上年同期为876535000港元，同比下降10.48%。可报告分部溢利为190762000港元，折合1.91亿港元；上年同期为242068000港元。本公司拥有人应占每股盈利为19.53港仙，上年同期为28.82港仙。（文章来源：南方财经网）
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.